Singh J A, Ramachandran R
University of Alabama at Birmingham, 510 20th Street South, FOT 805B, Birmingham, Alabama 35294, USA.
Bone Joint J. 2015 Oct;97-B(10):1385-9. doi: 10.1302/0301-620X.97B10.35696.
We assessed the age-related differences in the use of total shoulder arthroplasty (TSA) and outcomes, and associated time-trends using the United States Nationwide Inpatient Sample (NIS) between 1998 and 2010. Age was categorised as < 50, 50 to 64, 65 to 79 and ≥ 80 years. Time-trends in the use of TSA were compared using logistic regression or the Cochran Armitage test. The overall use of TSA increased from 2.96/100 000 in 1998 to 12.68/100,000 in 2010. Significantly lower rates were noted between 2009 and 2010, compared with between 1998 and 2000, for: mortality, 0.1% versus 0.2% (p = 0.004); discharge to an inpatient facility, 13.3% versus 14.5% (p = 0.039), and hospital stay > median, 29.4% versus 51.2% (p < 0.001). The rates of use of TSA/100,000 by age groups, < 50, 50 to 64, 65 to 79 and ≥ 80 years were: 0.32, 4.62, 17.82 and 12.56, respectively in 1998 (p < 0.001); and 0.65, 17.49, 75.27 and 49.05, respectively in 2010 (p < 0.001) with an increasing age-related difference over time (p < 0.001). Across the age categories, there were significant differences in the proportion: discharged to an inpatient facility, 3.2% versus 4.2% versus 14.7% versus 36.5%, respectively in 1998 (p < 0.001) and 1.8% versus 4.3% versus 12.5% versus 35.5%, respectively in 2010 (p < 0.001) and the proportion with hospital stay > median, 39.7% versus 40.2% versus 53% versus 69%, respectively in 1998 (p < 0.001) and 17.2% versus 20.6% versus 28.7% versus 50.7%, respectively in 2010 (p < 0.001). In a nationally representative sample, we noted a time-related increase in the use of TSA and increasing age-related differences in outcomes indicating a changing epidemiology of the use of TSA. Age-related differences in outcomes suggest that attention should focus on groups with the worst outcomes.
我们利用1998年至2010年美国全国住院患者样本(NIS)评估了全肩关节置换术(TSA)使用情况及疗效的年龄相关差异,以及相关的时间趋势。年龄分为<50岁、50至64岁、65至79岁和≥80岁。使用逻辑回归或 Cochr an Armitage检验比较TSA使用的时间趋势。TSA的总体使用量从1998年的2.96/10万增加到2010年的12.68/10万。与1998年至2000年相比,2009年至2010年的以下指标显著降低:死亡率,0.1%对0.2%(p = 0.004);转至住院机构,13.3%对14.5%(p = 0.039),以及住院时间>中位数,29.4%对51.2%(p < 0.001)。1998年,<50岁、50至64岁、65至79岁和≥80岁年龄组每10万人的TSA使用率分别为0.32、4.62、17.82和12.56(p < 0.001);2010年分别为0.65、17.49、75.27和49.05(p < 0.001),且随着时间推移年龄相关差异增大(p < 0.001)。在所有年龄类别中,转至住院机构的比例存在显著差异:1998年分别为3.2%、4.2%、14.7%和36.5%(p < 0.00),2010年分别为1.8%、4.3%、12.5%和35.5%(p < 0.001);住院时间>中位数的比例也存在显著差异:1998年分别为39.7%、40.2%、53%和69%(p < 0.001),2010年分别为17.2%、20.6%、28.7%和50.7%(p < 0.001)。在一个具有全国代表性的样本中,我们注意到TSA的使用随时间增加,且疗效的年龄相关差异增大,表明TSA使用的流行病学在变化。疗效的年龄相关差异表明应关注预后最差的群体。